News

QuidelOrtho Reveals Promising Revenue Projections for Q4

QuidelOrtho Reveals Promising Revenue Projections for Q4

QuidelOrtho Shares Preliminary Revenue Expectations for Fourth Quarter

QuidelOrtho Corporation (Nasdaq: QDEL), renowned for its innovative in vitro diagnostic technologies, has provided preliminary unaudited revenue figures for its fourth quarter, which ended on a promising note. This announcement reflects the company's commitment to continuous improvement and financial health, setting an optimistic tone for stakeholders and investors alike.

Projected Revenue for the Fourth Quarter of 2024

The Company anticipates its total reported revenues for the fourth quarter of 2024 will range between approximately $702 million and $707 million. This forecast aligns closely with QuidelOrtho's previously communicated financial guidance for the year. Notably, this estimation is bolstered by expected revenue from Labs, reinforcing the company’s robust operational framework.

Revenue Breakdown

Delving into specifics, the expected revenue structure for the fourth quarter is noteworthy. The projected figures include:

  • Non-respiratory reported revenue estimated at around $561 million to $563 million.
  • Respiratory reported revenue anticipated to be between $141 million to $143 million.

These projections not only indicate a strong closing quarter but also reflect the company's strategic investments and realignments over the previous year.

Leadership Insights on Financial Performance

Brian J. Blaser, President and CEO of QuidelOrtho, commented on the company's performance, stating, "We closed the year on a positive note and expect to deliver top-line results above the mid-point of our 2024 financial guidance. Fiscal 2024 was an important year for our Company; we focused our team on our highest growth and profit opportunities, realigned our leadership team, and improved our cost structure by executing on significant cost-savings initiatives." This perspective underscores the company's proactive approach to navigating the healthcare landscape.

Anticipating the Financial Results Report

QuidelOrtho is poised to disclose detailed financial results for the fourth quarter and the entire year of 2024 following the market's closure on a specified date. Once these results are available, a subsequent conference call will take place for discussions and insights regarding the outcomes achieved.

Those interested can access the call through the “Investor Relations” page on the Company’s website. Additionally, the Company plans to make its presentation materials available during the call, ensuring transparency and accessibility for all stakeholders.

Commitment to Advancing Diagnostics

QuidelOrtho remains dedicated to enhancing diagnostic capabilities to facilitate a healthier future. The company’s commitment extends beyond just numbers; it aims to transform healthcare delivery through actionable insights derived from its advanced diagnostic tools. By partnering with healthcare providers, QuidelOrtho seeks to illuminate pathways for improved patient outcomes across diverse settings.

Known for its leading expertise in various areas including immunoassays and molecular testing, QuidelOrtho recognizes the critical nature of providing accurate and swift diagnostics. This mission is integral to its operations, emphasizing the impact of timely diagnostics in clinical decision-making.

Frequently Asked Questions

What revenue figures did QuidelOrtho announce for Q4 2024?

QuidelOrtho expects total reported revenues for Q4 2024 to range from $702 million to $707 million.

What segments contributed to QuidelOrtho’s revenue expectations?

The projected revenues comprise approximately $561 million to $563 million from non-respiratory products and $141 million to $143 million from respiratory products.

What did the CEO say about the company's performance?

Brian J. Blaser stated that the Company expects top-line results above the mid-point of the 2024 financial guidance, highlighting strategic focus and cost-saving initiatives.

When will QuidelOrtho report its full-year results?

The Company plans to report its financial results for the fourth quarter and full year 2024 after the market closes on a designated date.

What is QuidelOrtho’s long-term vision?

QuidelOrtho is committed to advancing diagnostics for a healthier future, focusing on innovative solutions that improve patient care and clinical decision-making.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Shanghai Masters: Minhang's Vibe Enchants Visitors

Updated Category News Views 74

Minhang's Unique Blend of Action and Relaxation Tennis fans and journalists aren't exactly flocking to Minhang for a typical sports event feel. During the 2026 Rolex Shanghai Masters, something magical happened—intense tennis matches inside the court and a serene culinary oasis outside. You'd think these two worlds wouldn't mix, but Minhang pulled it off spectacularly....

Continue Reading
Understanding Cataracts: What Investors Should Know

Updated Category News Views 156

The Subtle Slowdown in Vision When it comes to cataracts, things don't just suddenly hit you like a ton of bricks. It’s a slow burn—cataracts develop over months or even years. Your vision starts feeling like it’s giving up on high definition. The lens in your eye starts to get cloudy, like a fog rolling in on a morning drive. You're not going to wake up one day...

Continue Reading
GrayMar’s Strategic Southeast Boost Could Reshape Market

Updated Category News Views 61

GrayMar’s Big Southeast Step Alright, let’s face it—when a company like GrayMar Environmental Services decides to go on a shopping spree, it’s a signal worth heeding, especially if they’ve got their eyes on expanding their empire across the Southeast. This time, it’s not just another map pin but a strategic play with heft. GrayMar’s picked up six locations...

Continue Reading
Replit Wins 2026 Microsoft Startup Partner Award

Updated Category News Views 76

Replit's Triumph in the Microsoft Ecosystem If there's one thing you come to expect from this dizzying dance of technology and business, it's that standout players get their due when they push the envelope. Replit just snagged a gleaming accolade by being named Microsoft's 2026 Partner of the Year for Startups. That's a hefty badge, especially coming from a giant like...

Continue Reading
Xinjiang Farmer Cultivates Community Success and Skills

Updated Category News Views 72

Growing Opportunities Beyond Tradition Zhang Xiying in Urumqi county, Xinjiang Uygur Autonomous Region, is rewriting the farming script with unflagging effort. She's not just tending to her own crops; she's nurturing a whole ecosystem of farmers who're hungry to branch out beyond traditional harvests. Picture this—a farmer turned agricultural technician, helping 19...

Continue Reading
Deadlines Loom for AppLovin Investors in Lawsuit

Updated Category News Views 85

Tough Times Ahead for AppLovin Investors If you're holding any AppLovin shares (NASDAQ: APP) and you caught wind of this class action, it's high time for some reflection. The clock is ticking down to November 16, 2026—just days away—and if you've felt the sting in your pocket over their securities, time's running short to throw your hat in the ring as a lead...

Continue Reading
Insulin Delivery Devices: A Billion-Dollar Surge

Updated Category News Views 45

When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...

Continue Reading
AI Shakes Up Boat Discovery: Traffic Soars for Leaders

Updated Category News Views 80

AI's Surge in the Boating World Well, look who’s riding the AI wave—it's our old friends at Boat Trader and YachtWorld, leaving the competition coughing in their slipstream. Similarweb data throws some cold, hard fish onto the deck, showing these two raking in over 17 times the AI-referred traffic compared to their closest peers. If you’re sniffing around for where...

Continue Reading
Festo's CIP Safety Module: Impacting Pneumatic Systems

Updated Category News Views 60

Festo's Pneumatic Safety Game-Changer Festo is stirring up quite a fuss at the Automation Fair in Boston this year, and it's not just hot air. Their new CPX-AP-A CIP Safety module is a standout. This jolt of innovation is geared to revolutionize the way safety is approached in pneumatic systems. The key? Seamless integration and robust performance, not to mention a...

Continue Reading
Voyageurs Park Honors Dark Skies with 2026 Recognition

Updated Category News Views 49

Voyageurs' Skyward Triumph: A Stellar Win for Conservation Ah, the night sky. That vast, galaxy-speckled canvas we too often ignore, drowned out by urban light pollution. But hey, not in Voyageurs National Park, no sir. This gem's just snagged the 2026 International Dark Sky Place of the Year Award, handed out by those watchful folks at DarkSky International. It's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Instacart and Ulta Beauty Forge Partnership for Fast Delivery

Updated Category News Views 132

Instacart and Ulta Beauty Join Forces for Same-Day Delivery In an exciting development for beauty enthusiasts and convenience seekers, Instacart (NASDAQ: CART), known for revolutionizing grocery technology in North America, is collaborating with Ulta Beauty (NASDAQ: ULTA), the leading specialty beauty retailer in the United States. This partnership is set to roll out...

Continue Reading
Advanced Wound Care Market Projected to Surge by 2030

Updated Category News Views 149

Observations on the Advanced Wound Care Market Growth The advanced wound care market is on a steady rise, projected to reach a remarkable valuation of $19.32 billion by the end of this decade. This growth trajectory represents a significant compound annual growth rate (CAGR) of 7.6%. Primary drivers for this expansion include the increasing geriatric population and the...

Continue Reading
Octopus AIM VCT 2 plc Enhances Shareholder Value with Buyback

Updated Category News Views 156

Octopus AIM VCT 2 plc Boosting Shareholder Confidence Octopus AIM VCT 2 plc is making significant strides in enhancing shareholder value through its recent share buyback program. The company has successfully purchased a total of 1,089,507 ordinary shares for cancellation. This strategic move reflects Octopus AIM's commitment to reinforcing its market position and...

Continue Reading
Explore ExchangeRight's Resilient $107 Million Investment Strategy

Updated Category News Views 76

ExchangeRight's Impressive $107 Million Portfolio Funding ExchangeRight has recently made headlines in the investment world by fully subscribing its remarkable $107 million Net-Leased Portfolio 66 DST. This achievement highlights the trust and confidence investors have in ExchangeRight, a well-known provider of various real estate DST and REIT investments. This portfolio...

Continue Reading
General Motors Reports Strong Q2 Results, Analysts Adjust Ratings

Updated Category News Views 205

General Motors Surprises with Strong Earnings General Motors Company (NYSE: GM) has recently announced its second quarter results, showcasing better-than-expected performance in both earnings and sales. With adjusted earnings per share reported at $2.53, GM has surpassed analyst forecasts, which estimated the figure to be around $2.40. Concurrently, the company's...

Continue Reading